...
首页> 外文期刊>Annals of surgical oncology >Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma
【24h】

Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma

机译:壶腹癌中端粒酶活性和人类端粒酶逆转录酶表达的预后意义

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Telomerase activity and human telomerase reverse transcriptase (TERT) have been reported as markers of tumor aggressiveness and poor prognosis in several digestive cancers. In the present study, we examined telomerase activity and TERT expression in ampullary carcinoma to determine whether these parameters could be used as indicators of aggressiveness and prognosis. Methods: Telomerase activity was analyzed by using the telomeric repeat amplification protocol assay, and TERT was examined by immunohistochemistry in ampullary carcinoma tissue samples resected from 46 patients. Results: Telomerase activity was detected in 42 (91.3%) ampullary carcinomas and 27 (58.7%) showed high activity, whereas TERT expression was detected in 35 (76.1%), including 21 with weak expression and 14 with strong expression. Univariate analysis revealed that histological grade (P = 0.029), tumor depth (P<0.001), nodal status (P = 0.013), UICC stage (P = 0.009), perineural invasion (P<0.001), and telomerase activity (P = 0.031) were significantly associated with disease-specific survival. In multivariate analysis, only telomerase activity remained an independent predictor of prognosis (P = 0.043). There was no statistical significance for survival among the three grades of TERT expression (P = 0.054); however, in subgroup analysis, patients with strong TERT expression showed significantly poorer prognosis than those without TERT expression (P = 0.013). Conclusions. Our results suggest that high telomerase activity and strong TERT expression may serve as new prognostic markers for evaluating the prognosis of patients with resected ampullary carcinoma.
机译:背景:端粒酶活性和人类端粒酶逆转录酶(TERT)已被报道为几种消化道肿瘤的侵袭性和不良预后的标志物。在本研究中,我们检查了壶腹癌中的端粒酶活性和TERT表达,以确定这些参数是否可以用作侵袭性和预后的指标。方法:采用端粒重复扩增方案分析端粒酶活性,并采用免疫组织化学方法对46例壶腹癌组织样本中的TERT进行检测。结果:在42例(91.3%)壶腹癌中检测到端粒酶活性,而在27例(58.7%)中检测到端粒酶活性,而在35例(76.1%)中检测到TERT表达,包括21例弱表达和14例强表达。单因素分析显示组织学分级(P = 0.029),肿瘤深度(P <0.001),淋巴结状态(P = 0.013),UICC分期(P = 0.009),神经周浸润(P <0.001)和端粒酶活性(P = 0.031)与疾病特异性生存率显着相关。在多变量分析中,只有端粒酶活性仍然是预后的独立预测因子(P = 0.043)。在三个等级的TERT表达中,生存率无统计学意义(P = 0.054)。然而,在亚组分析中,与未表达TERT的患者相比,具有高TERT的患者的预后明显较差(P = 0.013)。结论我们的结果表明,端粒酶活性高和TERT表达强可能是评估壶腹部切除患者预后的新预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号